"Closing volume" changes in alloxan-induced pulmonary edema in anesthetized dogs.
"Closing volume" (CV) was measured by the single-breath oxygen (SBO2) test in six dogs (alloxan group) before and after alloxan 100-200 mg/kg iv) was injected. CV increased significantly (P less than 0.05) from 32 +/- 3.2% (base line) to 45 +/- 3.5 % in period 1 (0-30 min after alloxan), but vital capacity (VC), respiratory system pressure volume (PV) curves, and alveolar plateau slopes did not change. No radiologic evidence of pulmonary edema was demonstrated in two dogs studied in period 1. CV decreased to 20 +/- 3.9% during period 2 (30-80 min after alloxan) and was associated with tracheal frothing, decreased VC, changes in the PV curve, and alveolar plateau slope, as well as histologic evidence of severe pulmonary edema. CV was 29 +/- 3.0%, and there were no changes in VC, PV curves, or alveolar plateau slopes in 6 other dogs studied for 2 h (control group). CV increased during period 1 before pulmonary edema could be demonstrated by changes in VC, PV curves, or radiography, but in period 2 lung function was so altered that CV by the SBO2 technique gave no useful information.
D000496:Alloxan; D000818:Animals; D001794:Blood Pressure; D004285:Dogs; D005263:Femoral Artery; D008168:Lung / Q000473:pathology; D008176:Lung Volume Measurements; D010100:Oxygen; D011654:Pulmonary Edema / Q000139:chemically induced / Q000503:physiopathology*; D013990:Tidal Volume
D000496:Alloxan; D010100:Oxygen